Partnering & Licensing
Servier Oncology
Servier Official Blog
Novice arhiv novic
31.5.2017: Servier and ILTOO Pharma sign a license option agreement for the clinical development and commercialization of low-dose interleukin-2 for the treatment of autoimmune diseases
3.5.2017: Servier and miRagen extend collaboration for the research, development and commercialization of microRNA-targeting therapeutics
26.4.2017: Servier and Vernalis plc announce achievement of 3 milestones in their oncology drug discovery collaboration
arhiv novic
Life Through Discovery: Servier’s 2015 corporate video
